Srinand Mandyam, MD
Interventional Pain Medicine · Lawrenceville, GANPI 1306162037
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $5,643 and has fallen 50.0% since, to $2,819 in 2025.
Across 186 payments — averaging $79.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Spinal Simplicity, LLC$2K
- Stimwave Technologies Incorporated$611
- Painteq LLC$552
- Boston Scientific$420
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$390
- plus $1K from 14 others
What the payments were for
- Consulting fees$2,00014%
- Speaking & faculty fees$3,20022%
- Travel & lodging$3,48724%
- Food & beverage$6,02941%
- Entertainment$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 77 | $9,544 |
| Spinal Simplicity, LLC | 15 | $2,198 |
| Stimwave Technologies Incorporated | 4 | $611 |
| Painteq LLC | 8 | $552 |
| Boston Scientific | 11 | $420 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $390 |
| Curonix LLC | 6 | $291 |
| Abbott | 6 | $235 |
| Collegium Pharmaceutical, Inc. | 8 | $128 |
| Foundation Fusion Solutions, LLC | 7 | $117 |
| Scilex Pharmaceuticals Inc. | 4 | $80 |
| Vertos Medical, Inc. | 1 | $62 |
| Forte Bio-pharma LLC | 1 | $33 |
| MDD US Operations, LLC | 2 | $32 |
| Vertiflex, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Trevena, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$5,803
- HA MINUTEMAN G3-R$1,799
- VANTA ADAPTIVESTIM$1,241
- VECTRIS$805
- StimQ Receiver Stimulator Kit Channel A US w Receiver$504
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$504
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$504
- Freedom 4A Receiver Kit Channel A US w Receiver$504
- Freedom 8A Receiver Kit Channel A US w Receiver$504
- PAINTEQ$389
- MYSTIM$168
- Proclaim Family of SCS IPGs$125
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$121
- OSTEOCOOL RF ABLATION$112
- INTELLIS$106
How this compares
$14,783 in reported general payments places this provider in the 80th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 170 | $141,051 |
| RelistorMethylnaltrexone Bromide | 28 | $65,264 |
| Buprenorphine | 180 | $52,867 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 931 | $32,452 |
| ZtlidoLidocaine | 30 | $27,885 |
| OxycontinOxycodone Hcl | 47 | $22,218 |
| Xtampza ErOxycodone Myristate | 46 | $20,515 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 868 | $19,228 |
| Oxycodone Hcl | 427 | $8,277 |
| Hysingla ErHydrocodone Bitartrate | 20 | $7,145 |
| Pregabalin | 284 | $7,108 |
| Gabapentin | 355 | $5,146 |
| Morphine Sulfate ErMorphine Sulfate | 254 | $4,984 |
| Lidocaine | 43 | $4,683 |
| Tramadol Hcl ErTramadol Hcl | 56 | $2,796 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $128 | $161,567216 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $390 | $65,26428 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $80 | $27,88530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Lawrenceville
- Ryan BudwanyLawrenceville$123K
- Oluwasegun LijofiLawrenceville$7K
- Sunay PatelLawrenceville$6K
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.